Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial. (Q41928494)
Jump to navigation
Jump to search
scientific article published on 28 September 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial. |
scientific article published on 28 September 2017 |
Statements
Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial (English)
Salmonella Typhi
1 reference
Christoph J Blohmke
Celina Jin
Maria Moore
Elizabeth Jones
James Meiring
Victoria Harris
Jonathan Gardner
Anna Nebykova
Simon A Kerridge
Jennifer Hill
Helena Thomaides-Brears
Ly-Mee Yu
28 September 2017